Assertion: inhalation suspension | /r/HasProperty | 0.25 to 1 mg total daily dose
Facets:
Source sentences:
text: The incidence of common adverse reactions is based on three double-blind, placebo-controlled, randomized U.S. clinical trials in which 945 patients, 12 months to 8 years of age, (98 patients ≥12 months and <2 years of age; 225 patients ≥2 and <4 years of age; and 622 patients ≥4 and ≤8 years of age) were treated with Budesonide Inhalation Suspension (0.25 to 1 mg total daily dose for 12 weeks) or vehicle placebo.